TCMScience: An Autonomous Scientist for Traditional Chinese Medicine
TLDR
TCMScience is an autonomous TCM knowledge-discovery agent that separates language-model proposals from execution, uses claim-support contracts, and evaluates network-pharmacology workflows.
Reasoning
The paper introduces a principled architecture for autonomous scientific discovery with extensive resource catalogs and a concrete case study, which are strengths. However, the abstract is truncated and lacks full quantitative results and explicit limitations, making the empirical evidence incomplete.
Read-first score
Read-first score 65.3, weighted from topical fit, citation, graph, method, reproducibility, and recency signals. Original total remains 72.
Field roles
Rank sensitivity
Stability: volatile; rank range: 25.
Keyword Scores
Deep Analysis
Innovations
- Separation of language-model proposals from execution and release authority
- Architecture combining a trusted kernel, a scientific compiler, and claim-support contracts
- Compilation of plans into typed operations with explicit execution permissions and pre-release checks for source provenance, study design, and claim scope
- Large model-independent resource layer: 117 public-source connectors with 444 typed operations across 29 domains, 150 native tools across 12 domains, and a TCM data hub with 136 databases, 76 dataset specifications, and 84,294 formula-source records
- Layered governance that jointly reduces release of erroneous outputs
Methodology
TCMScience uses a trusted kernel, scientific compiler, and claim-support contracts to compile language-model plans into typed operations, bound execution by explicit permissions, and check candidate findings against source provenance, study design, and claim scope before release. It integrates a capability registry of 117 public-source connectors with 444 typed operations across 29 domains, 150 native tools across 12 domains, and a TCM data hub cataloging 136 databases, 76 dataset specifications, and 84,294 formula-source records, supporting browser and local execution interfaces. Evaluations include a network-pharmacology analysis of Gegen Qinlian Tang and a governance ablation over 121 constructed erroneous outputs spanning 26 classes plus 10 compliant controls.
Key Results
In network-pharmacology analysis, replacing the whole-proteome background with the assayed-protein background changed significant pathways from 66 to zero, while incorporating inactive screening records identified nine pathways including drug-metabolism signals retained as mechanistic hypotheses. In the governance ablation, 121 errors were released without governance, 57 with the domain layer, 7 with the kernel, and 0 with both layers; all 10 compliant controls were retained.